JAG1 and endometrial cancer: Williams et al. [10] observed the decreased expression of NOTCH4 receptor, ligand JAG1, and downstream targets HES1 and HEY1 in low-grade endometrial cancer, indicating that overall Notch signaling is suppressed in low-grade endometrial cancer.